Source:http://linkedlifedata.com/resource/pubmed/id/17157509
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-1-8
|
pubmed:abstractText |
Prompted by our interest in neuroprotective agents with multiple mechanisms of action, we assessed the structure-activity relationship of a series of pentacycloundecylamine derivatives previously shown to have both L-type calcium channel blocking activity and N-methyl-d-aspartate receptor (NMDAR) antagonistic activity. We utilized a functional assay to measure NMDAR channel block using (45)Ca(2+) influx into synaptoneurosomes. The cage amine 8-benzylamino-8,11-oxapentacyclo[5.4.0.0(2,6). 0(3,10).0(5,9)]undecane (NPG1-01) proved to be the most potent experimental compound with an IC(50) of 2.98microM, while 8-amino-pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane had the next most potent IC(50) of 4.06microM. Increasing the polycyclic cage size of NGP1-01 from a pentacycloundecane to a tridecane cage structure, but retaining the N-benzyl moiety decreased potency 10-fold, indicating a limitation on the volume of the cage that can be accommodated in the channel binding site. In the presence of NGP1-01, NMDA/glycine-induced maximal (45)Ca(2+) influx was attenuated by 34% with an insignificant effect on agonist potency. These results are consistent with uncompetitive antagonism for this group of compounds. Radioligand binding studies with [(3)H]MK-801 or [(3)H]TCP showed little or no displacement of these ligands by pentacycloundecylamines, suggesting that the latter compounds bind to a unique site in the NMDAR channel. The pentacycloundecylamines tested represent a novel group of NMDAR antagonists that have potential as therapeutic agents for neurodegenerative diseases including Parkinson's and Alzheimer's disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amines,
http://linkedlifedata.com/resource/pubmed/chemical/Dizocilpine Maleate,
http://linkedlifedata.com/resource/pubmed/chemical/Excitatory Amino Acid Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Ion Channels,
http://linkedlifedata.com/resource/pubmed/chemical/Piperidines,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, N-Methyl-D-Aspartate,
http://linkedlifedata.com/resource/pubmed/chemical/Thiophenes,
http://linkedlifedata.com/resource/pubmed/chemical/tenocyclidine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0968-0896
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1525-32
|
pubmed:meshHeading |
pubmed-meshheading:17157509-Amines,
pubmed-meshheading:17157509-Animals,
pubmed-meshheading:17157509-Brain,
pubmed-meshheading:17157509-Dizocilpine Maleate,
pubmed-meshheading:17157509-Excitatory Amino Acid Antagonists,
pubmed-meshheading:17157509-Ion Channels,
pubmed-meshheading:17157509-Male,
pubmed-meshheading:17157509-Mice,
pubmed-meshheading:17157509-Mice, Inbred ICR,
pubmed-meshheading:17157509-Models, Molecular,
pubmed-meshheading:17157509-Piperidines,
pubmed-meshheading:17157509-Radioligand Assay,
pubmed-meshheading:17157509-Receptors, N-Methyl-D-Aspartate,
pubmed-meshheading:17157509-Structure-Activity Relationship,
pubmed-meshheading:17157509-Synaptosomes,
pubmed-meshheading:17157509-Thiophenes
|
pubmed:year |
2007
|
pubmed:articleTitle |
Structure-activity relationships of pentacycloundecylamines at the N-methyl-d-aspartate receptor.
|
pubmed:affiliation |
Department of Pharmaceutical Sciences, Northeastern Ohio Universities College of Pharmacy, Rootstown, OH 44272-0095, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|